MBL-1
MBL-1 is an orally active anti-inflammatory agent. MBL-1 can be isolated from the fermentation broth of Aspergillus sp. derived from gorgonians. MBL-1 inhibits the activity of the hCOX-2 protein with an IC50 of 5.77 μM. MBL-1 reduces the production of key pro-inflammatory mediators such as NO, ROS, IL-1β and IL-18 by inhibiting the MAPK/NF-κB and NLRP3 signaling pathways. MBL-1 exerts a protective effect against DSS-induced colitis. MBL-1 can be used for the research of ulcerative colitis.
For research use only. We do not sell to patients.
- CAS No.: 1815632-13-3
- Formula: C25H26O7
- Molecular Weight:438.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Endogenous Metabolite Isoforms
More
Biological Activity
|
Fungal Metabolite |
hCOX-2 5.77 μM (IC50) |
NLRP3 |
IL-1β |
IL-18 |
MBL-1 potently inhibits the activity of hCOX-2 protein, with an IC50 value of 5.77 μM[1].
MBL-1 (0.5-50 μM; 24 h) shows no cytotoxicity in RAW 264.7, J774A.1 and MCF-7 cells even at the highest concentration of 50 μM[1].
MBL-1 (2-30 μM; 1 h) inhibits NO production in LPS-stimulated RAW 264.7 cells in a dose-dependent manner[1].
MBL-1 (2-30 μM; 1 h) dose-dependently inhibits LPS-induced ROS production in RAW 264.7 cells [1].
MBL-1 (2-30 μM; 1 h) inhibits the production of cytokines IL-6, IL-10 and IL-1β in LPS-stimulated RAW 264.7 cells in a dose-dependent manner[1].
MBL-1 (2-30 μM) dose-dependently inhibits LPS-induced phosphorylation of p38, ERK and JNK proteins in RAW 264.7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 J (male, 7 weeks old, DSS-induced colitis model)[1]
-
Dosage:25 mg/kg; 50 mg/kg
-
Administration:p.o.; once daily; 7 days
-
Result:Mitigated DSS-induced body weight loss in a dose-dependent manner.
Attenuated progressive elevation of DAI scores in a dose-dependent manner.
Preserved colonic length in a dose-dependent manner, with 50 mg/kg dose resulting in a statistically significant increase compared to DSS-only controls.
Alleviated mucosal ulceration, preserved epithelial integrity, and reduced inflammatory cell infiltration; 50 mg/kg dose resulted in a statistically significant reduction in histological scores compared to DSS-only controls.
Chemical Information
-
CAS No. 1815632-13-3
-
Molecular Weight 438.47
-
Formula C25H26O7
-
SMILES
COC([C@@]1(OC(C(OC)=C1C2=CC=C(C=C2)O)=O)CC3=CC(C/C=C(C)\C)=C(C=C3)O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz